Main Menu

Cancer Pharmacology and Stress Response Team 

Dr Olivia Rossanese is the interim leader of the Cancer Pharmacology and Stress Response team. The team was previously led by Dr Vladimir Kirkin, who left the ICR in June 2020. The team assesses activity of novel molecularly targeted anti-cancer agents in preclinical models of cancer – a key requirement for evidence-based drug development.

Team leader

Dr Olivia Rossanese

Dr Olivia Rossanese

Dr Olivia Rossanese is Interim Director of the Cancer Research UK Cancer Therapeutics Unit and Interim Head of the Division of Cancer Therapeutics. She is investigating new therapeutic targets for the treatment of cancer and examining the molecular consequences of their inhibition in cancer cells and tumours.

ORCID 0000-0002-1262-9522

Team members

Gary Box

Higher scientific officer

Will Court

Senior scientific officer

Sharon Gowan

Senior scientific officer

Albert Hallsworth

Higher Scientific Officer

Alexis de haven Brandon

Higher scientific officer

Melanie Valenti

Senior scientific officer

Sally Wells

Personal Assistant 020 8722 4043